Compare ADUS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADUS | HTFL |
|---|---|---|
| Founded | 1979 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.4B |
| IPO Year | 2009 | N/A |
| Metric | ADUS | HTFL |
|---|---|---|
| Price | $101.35 | $20.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $136.40 | $39.20 |
| AVG Volume (30 Days) | 200.1K | ★ 1.3M |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.40 | N/A |
| EPS | ★ 5.22 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.17 | $40.42 |
| Revenue Next Year | $4.64 | $22.73 |
| P/E Ratio | $19.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $88.96 | $20.13 |
| 52 Week High | $124.44 | $41.22 |
| Indicator | ADUS | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 36.40 | 34.74 |
| Support Level | N/A | $20.13 |
| Resistance Level | $119.48 | $25.05 |
| Average True Range (ATR) | 3.80 | 1.42 |
| MACD | -0.74 | -0.06 |
| Stochastic Oscillator | 4.74 | 2.05 |
Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.